SEC Form 4 · accession 0001179110-17-013439
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel Gesua Sive Salvadori
Officer — Executive Vice President
Period of report
Oct 23, 2017
Accepted (ET)
Oct 25, 2017 · 5:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Oct 23, 2017 | M | 68,284 | $42.08 | A | 142,082 | D | |
| Common shares without par value | Oct 23, 2017 | M | 28,319 | $47.00 | A | 170,401 | D | |
| Common shares without par value | Oct 23, 2017 | S | 96,603 | $56.21 | D | 73,798 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option (right to buy)F1 | $42.08 | Oct 23, 2017 | M | 34,142 | D | Sep 26, 2016 | Sep 25, 2024 | Common shares | 34,142 | 34,142 | D |
| Option (right to buy)F1 | $42.08 | Oct 23, 2017 | M | 34,142 | D | Sep 26, 2017 | Sep 25, 2024 | Common shares | 34,142 | 0 | D |
| Option (right to buy)F1 | $47.00 | Oct 23, 2017 | M | 28,319 | D | Feb 20, 2016 | Feb 19, 2025 | Common shares | 28,319 | 70,798 | D |
Explanation of responses
- F1Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Remarks
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).